Delivery Order SPE2DB22D3501-SPE2DB25FWV93
- Not listed
- The Defense Logistics Agency awarded a $19,748.97 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units. The contract employs firm fixed-price pricing with no set-aside designation and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a $17,169.05 delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.45 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $2,400.84 for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. This contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,095.47. This firm fixed-price delivery order, which is set to be completed by July 23, 2025, represents a single-transaction pharmaceutical procurement from the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $18,928.44 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Losartan-HCTZ 50-12.5 mg tablets (90-count), valued at $2,297.83 with a firm fixed price structure. The award, issued on August 1, 2025, is set to complete by August 4, 2025. This is a non-set-aside competitive award with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $5,910.20 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. This firm fixed-price delivery order, which is not set-aside designated, is set to complete on July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units, with a ceiling value of $2,609.93. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 22, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,456.18 delivery order on August 14, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count). This competitive award utilized firm fixed price contracting with no set-aside designation and an ultimate completion date of August 15, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWV93Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,317.00 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a quantity of 90 units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's delivery orders through the DLA Troop Support Medical prime contract vehicle encompass a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a child contract under the larger SPE2DX IDC, this delivery order for Losartan-HCTZ represents routine pharmaceutical fulfillment within AmerisourceBergen's established role as a primary distributor for federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/13/25 |